We present a 79-yr-old white woman admitted to the hospital with diffuse myalgias and muscle weakness associated with eosinophilia. Examination of a muscle biopsy section revealed eosinophilic myositis with vasculitis. This association is infrequent and we describe the first case report with symmetrical polyneuropathy. The treatment with prednisone (60 mg/day) led to a complete clinical-pathological recovery of the disease. We review the differential diagnosis and the aetiopathogenic mechanism.
E myositis (EM) is an infrequent form of inflammatory muscle disease associated with peripheral blood, bone marrow and/or tissue eosinophilia. Although the aetiology is usually unknown, it may be associated with the intake of drugs or products which contain -tryptophan and with tumours [1, 2] . The diagnosis is fundamentally histological after muscle biopsy. Approximately 31 case reports have been described in the medical literature, most of them with resolution after treatment with prednisone or indomethacin [3] . In this article, we present a new case report of EM which was resolved favourably after steroid treatment. In contrast to other cases previously described, this patient presented EM associated with necrotizing vasculitis and symmetrical polyneuropathy.
CASE REPORT
A 79-yr-old white woman was admitted to our hospital because of polymyalgias and eosinophilia.
The patient had been in good health until 14 days prior to her admission, when she began to have diffuse myalgias and developed severe muscle aches in her upper and lower extremities, along with severe proximal and distal muscle weakness which made it impossible for her to walk. She reported that 15 days prior to the onset of symptoms, she suffered a trauma in her house. There was no history of cough, dyspnoea, haemoptysis, chest pain, fever, arthralgia, arthritis, anorexia, weight loss, vasculitis, rash, dermal lesions, peripheral oedema, alopecia, intake of -tryptophancontaining products, Raynaud's phenomenon, rhinitis or sinusitis, or oral ulcers or inflammatory eye disease.
Among her antecedents were bronchiectatic syndrome with various admissions for bronchospasm associated with acute bronchial colds, although she never had eosinophilia in these episodes. She did have non-insulin-dependent diabetes mellitus undergoing treatment with oral anti-diabetics of short evolution and a cholecystectomy 6 yr previously. There was no intake of denatured rapeseed oil, well water, meat or unpasteurized milk, no trips to tropical countries or contact with animals, no consumption of tobacco or alcohol, and no history of atopic diseases or drug allergies.
Body temperature was 36.5°C, pulse 70/min and the respiration rate 15/min. Blood pressure was 140/70 mmHg. On examination, the patient was a thin woman who appeared well. The head, neck, lungs, heart, breasts and abdominal examination were normal. Neurological examination showed weakness in the upper and lower extremities (more accentuated in scapular and pelvic waist), intense pain upon movement of the muscle groups, as well as loss of tendon reflexes in a symmetrical form without signs of pyramidalism. Rectal examination was normal and a stool specimen gave a negative test for occult blood.
Laboratory studies showed that the white blood cell count was 35 300/mm 3 with 62% eosinophils in matured state with some forms which showed partially degranulated cytoplasm, the haematocrit was 45%, the haemoglobin level was 14.9 g/100 ml and the platelet count was 290 000/mm 3 . The ESR was 6 mm in the first hour, the creatine kinase (CK) level was 751 U/l (normal 10-195 at the laboratory used), the aldolase level was 13.3 U/l (normal Q7), the RF level was 531 IU/ml (normal Q20), the CRP was 42 mg/l (normal Q5.5), glycaemia was 251 mg/dl and total serum IgE 1136 IU/ml (normal 0-100). Serum complement factors C3 and C4 were 92 mg/dl (normal 122-190) and 17 mg/dl (normal 22-36), respectively, and immunocomplexes were 26% (normal Q20). There were negative findings on tests for ANA, anti-DNA, ANCA, Jo1 antibodies, and on serological studies for Lyme disease, HIV, hepatitis B, Echinococcus, Ascaris, Brucella, Salmonella, Trichinella, Borrelia, Leishmania and rickettsias. The arterial gasometry was (FiO2 21%): pH 7.47, pCO2 40 mmHg, pO2 71 mmHg, HCO3 30 mmol/l, O2 Sat 95%. Renal and hepatic function studies were within the reference range. Serum angiotensin-converting enzyme was normal.
ECG (echocardiogram), abdominal ultrasound, intestinal transit and CT of cranium and abdomen were normal. The spirometry presented reversible obstruction with FVC 1.740 l (87% of predicted), FEV1 1.040 l (70% of predicted) and FEV1/FVC index of 60% with an increase of the FEV1 after the administration of salbutamol of 46% (normal for predicted). A chest roentgenogram showed some increased Submitted 14 March 1996 ; revised version accepted 11 July 1996. Correspondence to: A. Espino-Montoro, Servicio de Medicina Interna, Hospital Universitario de la Merced, Avda. de la Constitucio´n 2, 41640 Osuna (Sevilla), Spain. radiotransparency in both lungs and slight peribronchial thickening, and there were no infiltrates or interstitial pattern. Aspirated bone marrow showed manifest normocellular bone marrow and increased eosinophils probably reactive, excluding acute or chronic haematological malignancy. The electroneurogram in the lower extremities was consistent with a symmetrical polyneuropathy. The electromyogram showed a myopathic pattern: potentials of low amplitude, polyphasic with early recruitment and fibrillation.
Histological analysis
A muscle biopsy was performed on the left quadriceps. One formalin-fixed, paraffin-embedded and haematoxylin and eosin (H & E)-stained muscle biopsy specimen was analysed and special techniques were used: trichromic, reticulin and stain for elastic fibres. The morphological characteristics were an eosinophilic myositis and a necrotizing vasculitis on blood vessels of medium size. At the level of the muscle, there appeared an intense inflammatory infiltrate of eosinophilic predominance in the perimysium, epimysium and endomysium with necrotizing muscle fibres. Several blood vessels of medium size related to the muscle showed an intense inflammatory infiltrate with eosinophilia at the level of the blood vessel wall, as well as necrosis in same and obliteration of its lumen (necrotizing vasculitis). Serial slices were made and neither granulomas nor parasites were found. With these findings, the diagnosis of eosinophilic myositis with vasculitis was made. The muscle biopsy specimen revealed no evidence of fasciitis (Fig. 1) . The muscle biopsies were revised in a referred pathology laboratory.
The patient was treated with corticosteroid (60 mg/day of prednisone) orally. There was prompt and complete resolution of the clinical and laboratory abnormalities, including normalization of the CK, RF, CRP and IgE levels, and eosinophil count in 1 week together with improvement of the polyneuropathy. Reduction of the prednisone dosage during the following 3 months was not associated with a recurrence of the peripheral eosinophilia or an increment of the CK level. There has been no recurrence during a 1 yr follow-up. DISCUSSION EM is an infrequent syndrome in humans, but well described in animals [4] , which produces inflammation of the masticator muscles [5] . It may be focal or generalized and may be associated with systemic clinical manifestations which resemble autoimmune or immunologically mediated idiopathic disease. Its aetiology is unknown, although a few drugs or toxins have been described which can induce myopathy and eosinophilia, such as -tryptophan [1] , Tranilast, -penicillamine, hydralazine, procainamide, cimetidine, phenytoin and ethanol [6] [7] [8] [9] [10] . Its pathogenesis is not well known, although it is believed that it is due to the infiltration, activation and degranulation of eosinophils which leads to the release of cytotoxic granule proteins which results in tissue damage [3] . In our case report, the antecedent of a previous trauma and the presence of eosinophils with partially degranulated cytoplasm could very well explain this pathogenic mechanism.
EM most frequently affects women rather than men (2:1) and the clinical manifestations are muscle pain, cramping, or tenderness; upper or lower extremity swelling/oedema; muscle weakness; arthralgias/ arthritis and myocarditis/pericarditis. Exceptionally, the following have been described: vasculitis, inflammatory eye disease, Raynaud's phenomenon, eosinophilic pneumonia and angioedema. It is worth noting that the presence of fever and constitutional syndrome are rare with this disease. Among laboratory findings we find eosinophilia, an increase in the ESR, CK and aldolase and positive RF [3] [ Table I] .
Although the age range in which EM may manifest itself is wide (14-70 yr of age), our patient is the most elderly (79 yr of age). In order to arrive at the diagnosis of EM, it is necessary to exclude an entire series of underlying toxic, neoplastic, infectious and systemic processes which may confuse us regarding the said entity. Within the infectious diseases which can lead to eosinophilia and myopathy, we have the following: infestation by helminths (Ascaris, Trichinella and Echinococcus), bacteria (rickettsias), viral infection (HIV) and protozoa (Leishmania). Within the systemic diseases, we have fundamentally sarcoidosis and diseases of the connective tissue. In our case, we can exclude the presence of all of these processes because of the data included in the clinical history, laboratory studies and histological analysis.
Idiopathic hypereosinophilic syndrome was ruled out because no cardiac involvement existed and peripheral myopathy appears to be rare [11] . The systemic necrotizing vasculitis such as Churg-Strauss syndrome (CSS) [12] , eosinophilic fasciitis [13] and toxic oil syndrome [14] were excluded because none of the following manifestations were documented: fever, constitutional syndrome, cutaneous alterations, clearcut pulmonary affectations or asthma, sinusitis or rhinitis, intake of denatured rapeseed oil, formation of extravascular granulomas and fasciitis. However, our patient had extra-pulmonary involvement of two organs (muscle and nerve), and an appropriately high eosinophil count and antecedents of bronchiectatic syndrome with various admissions for bronchospasm which could lead to confusion with the CSS. The episodes of bronchospasm were related to a previously known bronchiectasis and coincident with acute bronchial infection, and, in addition, the patient did not have asthma or pulmonary affectation or bronchospasm, or a previous history of atopic disease, rhinitis or allergy during the admission for acute myositis. The CSS begins as an initial allergic disease, usually allergic rhinitis, evolving into asthma, followed by peripheral blood eosinophilia and finally a systemic vasculitis [12] with poor initial response to corticoids, in contrast to our case report. Following the ACR criteria for the classification of CSS, neither the traditional format classification nor the classification tree are fulfilled for the diagnosis of CSS [15] . In our case report, necrotizing vasculitis was evident in the histological analysis, but was limited to the affected muscles (non-systemic). Eosinophilia-myalgia syndrome (EMS) [16] [17] [18] presents findings which are histologically similar to EM (Table I) . However, the presence of myositis, the increase in the levels of CK, the absence of a previous intake of -tryptophan compounds and the positive response to treatment make us exclude EMS. The patient presented symmetrical polyneuropathy and we may not completely rule out that this affectation was secondary to her diabetes mellitus or vasculitis. However, non-insulin-dependent diabetes mellitus was of short evolution and the clinical manifestations became evident after the onset of the disease, disappearing with steroid treatment. The presence of necrotizing vasculitis in the histological analysis is of interest. The relationship between these findings and the pathogenesis of EM is not well known. We may speculate that this may reflect an autoimmune aetiology, even though the following serological studies, ANA, anti-DNA, ANCA, etc., present in autoimmune diseases were negative in this patient. In spite of this, the alterations of other less specific tests, such as the RF, CRP, IgE, eosinophilia, immunocomplexes and serum complement, along with the good response to treatment with normalization of the parameters, would speak in favour of an autoimmune aetiology.
In conclusion, EM is a rare form of myositis with a favourable prognosis. In some individuals, the use of certain drugs may indicate the aetiological agent; however, in our case report, as with the majority of patients, the aetiology remains unclear. In this patient, the antecedent of a previous trauma may have been the stimulus that produced the tissue damage. However, the presence of necrotizing vasculitis together with immunocomplex alterations, RF and serum complement can probably explain why the autoimmune aetiology may have an important role in this disease. This is the first case report of EM associated with vasculitis and symmetrical polyneuropathy.
